Pharmacotherapy of hepatocellular carcinoma

Author： Perry John F   Strasser Simone I   George Jacob   Farrell Geoffrey C   McCaughan Geoffrey W  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2175-2185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma

By Feitelson Mark A   Clayton Marcia M   Reis Helena MGPV   Wu Guoyi   Lu Eva Ping  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2233-2245

Informa Healthcare

Access to resources Recommend Favorite

Targeting integrins in hepatocellular carcinoma

By Wu Yanhua   Qiao Xiaojing   Qiao Shouyi   Yu Long  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 4, 2011-04 ,pp. : 421-437

Informa Healthcare

Access to resources Recommend Favorite

Transarterial therapies for hepatocellular carcinoma

By Sangro Bruno   D'Avola Delia   Iññarrairaegui Mercedes   Prieto Jesus  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1057-1073

Informa Healthcare

Access to resources Recommend Favorite

Contemporary management of hepatocellular carcinoma

By Palmer Daniel  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 442-447

Royal College Of Physicians

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene   Keating Gillian M.  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite